Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Therapeutic Advances in Respiratory Disease|January 31, 2018
A review of the in vitro and in vivo valved holding chamber (VHC) literature with a focus on the AeroChamber Plus Flow-Vu Anti-static VHCSanjeeva Dissanayake, Jason Suggett
Pulmonary Therapy|March 12, 2026
Climate Change and the Switch from Pressurised Metered-Dose Inhalers to Dry Powder Inhalers: A Proportionate Balancing of Risk and Reward?Sanjeeva Dissanayake, Jason Suggett, Alan Kaplan
AAPS Pharmscitech|May 14, 2016
Clinically Relevant In Vitro Testing of Orally Inhaled Products-Bridging the Gap Between the Lab and the PatientJolyon P Mitchell, Jason Suggett, Mark Nagel
Hospital Pharmacy|October 28, 2024
A Novel Common Canister Protocol for Albuterol Sulfate Metered Dose Inhalers: Conservation Strategy and Clinical Outcomes Amid COVID-19 PandemicMei Tsai, Jason Suggett, Anthony Co, et al.
Pulmonary Pharmacology & Therapeutics|October 13, 2017
Are valved holding chambers (VHCs) interchangeable? An in vitro evaluation of VHC equivalenceSanjeeva Dissanayake, Mark Nagel, Emanuela Falaschetti, et al.
Canadian Respiratory Journal|February 19, 2019
Cost-Effectiveness of the Aerobika® Oscillating Positive Expiratory Pressure Device in the Management of Chronic Obstructive Pulmonary Disease Exacerbations in CanadaNguyen Xuan Thanh, Philip Jacobs, Jason Suggett, et al.
Canadian Respiratory Journal|June 26, 2019
Corrigendum to "Cost-Effectiveness of the Aerobika® Oscillating Positive Expiratory Pressure Device in the Management of Chronic Obstructive Pulmonary Disease Exacerbations in Canada"Nguyen Xuan Thanh, Philip Jacobs, Jason Suggett, et al.
International Journal of Chronic Obstructive Pulmonary Disease|October 29, 2020
Impact of Oscillating Positive Expiratory Pressure Device Use on Post-Discharge Hospitalizations: A Retrospective Cohort Study Comparing Patients with COPD or Chronic Bronchitis Using the Aerobika<sup>®</sup> and Acapella<sup>®</sup> DevicesJenny Tse, Keiko Wada, Yi Wang, et al.
Respiratory Medicine|April 2, 2018
In vitro and clinical characterization of the valved holding chamber AeroChamber Plus<sup>®</sup> Flow-Vu<sup>®</sup> for administrating tiotropium Respimat<sup>®</sup> in 1-5-year-old children with persistent asthmatic symptomsHerbert Wachtel, Mark Nagel, Michael Engel, et al.
Pulmonary Therapy|February 7, 2020
A Real-World Evidence Study Assessing the Impact of Adding the Aerobika Oscillating Positive Expiratory Pressure Device to Standard of Care Upon Healthcare Resource Utilization and Costs in Post-Operative PatientsChakkarin Burudpakdee, Aimee M Near, Huan Huang, et al.
Pageof 2